A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer. - Yang Y; Chang J; Huang C; Zhang Y; Wang J; Shu Y; Burillon JP; Riggi M; Petain A; Ferre P; Liang Y; Zhang L (Journal of thoracic disease, 2019)